These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15175019)

  • 1. A theta-defensin composed exclusively of D-amino acids is active against HIV-1.
    Owen SM; Rudolph D; Wang W; Cole AM; Sherman MA; Waring AJ; Lehrer RI; Lal RB
    J Pept Res; 2004 Jun; 63(6):469-76. PubMed ID: 15175019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RC-101, a retrocyclin-1 analogue with enhanced activity against primary HIV type 1 isolates.
    Owen SM; Rudolph DL; Wang W; Cole AM; Waring AJ; Lal RB; Lehrer RI
    AIDS Res Hum Retroviruses; 2004 Nov; 20(11):1157-65. PubMed ID: 15588337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrocyclin-2: structural analysis of a potent anti-HIV theta-defensin.
    Daly NL; Chen YK; Rosengren KJ; Marx UC; Phillips ML; Waring AJ; Wang W; Lehrer RI; Craik DJ
    Biochemistry; 2007 Sep; 46(35):9920-8. PubMed ID: 17685559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrocyclin, an antiretroviral theta-defensin, is a lectin.
    Wang W; Cole AM; Hong T; Waring AJ; Lehrer RI
    J Immunol; 2003 May; 170(9):4708-16. PubMed ID: 12707350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry.
    Yasin B; Wang W; Pang M; Cheshenko N; Hong T; Waring AJ; Herold BC; Wagar EA; Lehrer RI
    J Virol; 2004 May; 78(10):5147-56. PubMed ID: 15113897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The theta-defensin, retrocyclin, inhibits HIV-1 entry.
    Münk C; Wei G; Yang OO; Waring AJ; Wang W; Hong T; Lehrer RI; Landau NR; Cole AM
    AIDS Res Hum Retroviruses; 2003 Oct; 19(10):875-81. PubMed ID: 14585219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrocyclin RC-101 overcomes cationic mutations on the heptad repeat 2 region of HIV-1 gp41.
    Fuhrman CA; Warren AD; Waring AJ; Dutz SM; Sharma S; Lehrer RI; Cole AL; Cole AM
    FEBS J; 2007 Dec; 274(24):6477-87. PubMed ID: 18028423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical effects of two theta-defensins on HIV type 1 infection.
    Wang Q; Wang W; Zheng J; Tabibian S; Xie Y; Song J; Waring AJ; Chiu R; Yang OO; Chen IS; Lehrer RI; Pang S
    AIDS Res Hum Retroviruses; 2007 Apr; 23(4):508-14. PubMed ID: 17506607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of alpha- and theta-defensins against primary isolates of HIV-1.
    Wang W; Owen SM; Rudolph DL; Cole AM; Hong T; Waring AJ; Lal RB; Lehrer RI
    J Immunol; 2004 Jul; 173(1):515-20. PubMed ID: 15210812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial polypeptides are key anti-HIV-1 effector molecules of cervicovaginal host defense.
    Cole AM; Cole AL
    Am J Reprod Immunol; 2008 Jan; 59(1):27-34. PubMed ID: 18154593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of alpha-, beta-, and theta-defensins with influenza A virus and surfactant protein D.
    Doss M; White MR; Tecle T; Gantz D; Crouch EC; Jung G; Ruchala P; Waring AJ; Lehrer RI; Hartshorn KL
    J Immunol; 2009 Jun; 182(12):7878-87. PubMed ID: 19494312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theta-defensins prevent HIV-1 Env-mediated fusion by binding gp41 and blocking 6-helix bundle formation.
    Gallo SA; Wang W; Rawat SS; Jung G; Waring AJ; Cole AM; Lu H; Yan X; Daly NL; Craik DJ; Jiang S; Lehrer RI; Blumenthal R
    J Biol Chem; 2006 Jul; 281(27):18787-92. PubMed ID: 16648135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. theta-Defensin pseudogenes in HIV-1-exposed, persistently seronegative female sex-workers from Thailand.
    Yang C; Boone L; Nguyen TX; Rudolph D; Limpakarnjanarat K; Mastro TD; Tappero J; Cole AM; Lal RB
    Infect Genet Evol; 2005 Jan; 5(1):11-5. PubMed ID: 15567134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An anti-HIV microbicide engineered in commensal bacteria: secretion of HIV-1 fusion inhibitors by lactobacilli.
    Pusch O; Kalyanaraman R; Tucker LD; Wells JM; Ramratnam B; Boden D
    AIDS; 2006 Oct; 20(15):1917-22. PubMed ID: 16988512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral activity of retrocyclin RC-101, a candidate microbicide against cell-associated HIV-1.
    Gupta P; Lackman-Smith C; Snyder B; Ratner D; Rohan LC; Patton D; Ramratnam B; Cole AM
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):391-6. PubMed ID: 22924614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1.
    Cole AM; Hong T; Boo LM; Nguyen T; Zhao C; Bristol G; Zack JA; Waring AJ; Yang OO; Lehrer RI
    Proc Natl Acad Sci U S A; 2002 Feb; 99(4):1813-8. PubMed ID: 11854483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 adapts to a retrocyclin with cationic amino acid substitutions that reduce fusion efficiency of gp41.
    Cole AL; Yang OO; Warren AD; Waring AJ; Lehrer RI; Cole AM
    J Immunol; 2006 Jun; 176(11):6900-5. PubMed ID: 16709850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of primate theta-defensins: a serpentine path to a sweet tooth.
    Nguyen TX; Cole AM; Lehrer RI
    Peptides; 2003 Nov; 24(11):1647-54. PubMed ID: 15019196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4 mimetic miniproteins: potent anti-HIV compounds with promising activity as microbicides.
    Van Herrewege Y; Morellato L; Descours A; Aerts L; Michiels J; Heyndrickx L; Martin L; Vanham G
    J Antimicrob Chemother; 2008 Apr; 61(4):818-26. PubMed ID: 18270220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reawakening retrocyclins: ancestral human defensins active against HIV-1.
    Venkataraman N; Cole AL; Ruchala P; Waring AJ; Lehrer RI; Stuchlik O; Pohl J; Cole AM
    PLoS Biol; 2009 Apr; 7(4):e95. PubMed ID: 19402752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.